New Jersey Turnpike Interchange Widening Program
Sector: Road • Location: New Jersey, United States
Source: Highways Today
AECOM has been selected to provide program management services for the New Jersey Turnpike Authority's $1.1 billion Interchange 1 to 4 Widening Program. The program aims to increase mainline capacity and expand interchange operations over a 36.5 mile stretch of the New Jersey Turnpike, reducing congestion and improving environmental conditions.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | ongoing |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | AECOM has been selected to provide program management services for the New Jersey Turnpike Authority's $1.1 billion Interchange 1 to 4 Widening Program. The program aims to increase mainline capacity and expand interchange operations over a 36.5 mile stretch of the New Jersey Turnpike, reducing congestion and improving environmental conditions. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |
More Road projects in United States
- Engineering, Procurement, and Construction of Third Bosphorus Bridge
- Morphotek’s New Biologics Production Facility
- LabCentral 238, Cambridge, Massachusetts, USA
- Kite Pharma’s Viral Vector Manufacturing Facility, California, US
- Eli Lilly’s Parenteral Product and Device Manufacturing Facility, Concord, North Carolina
- Amgen’s Drug Substance Manufacturing Plant, Wake County, North Carolina
- Vertex Pharmaceuticals’ Boston Campus
- Roche Diagnostics PCR Diagnostic Kits
